Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice
about
Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalkD2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHDDopamine D2 receptors mediate two-odor discrimination and reversal learning in C57BL/6 miceThe pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomasDo Dopaminergic Impairments Underlie Physical Inactivity in People with Obesity?60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axisTargeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesisThe role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout miceSuppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallinThe D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn miceDopamine receptor 1 neurons in the dorsal striatum regulate food anticipatory circadian activity rhythms in miceActivation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin geneDopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropesD2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIPDopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatumFacilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient miceSimultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice.D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes.Dopamine is necessary for cue-dependent fear conditioning.Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice.Distinct motor impairments of dopamine D1 and D2 receptor knockout mice revealed by three types of motor behavior.GAP1(IP4BP)/RASA3 mediates Galphai-induced inhibition of mitogen-activated protein kinase.Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter.Prolactin induces apoptosis of lactotropes in female rodents.Dopamine-regulated adrenocorticotropic hormone secretion in lactating rats: functional plasticity of melanotropes.Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors.Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment.Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor.Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain.Genesis of prolactinomas: studies using estrogen-treated animalsEthanol alters production and secretion of estrogen-regulated growth factors that control prolactin-secreting tumors in the pituitaryDistinct roles for Galpha(i)2 and Gbetagamma in signaling to DNA synthesis and Galpha(i)3 in cellular transformation by dopamine D2S receptor activation in BALB/c 3T3 cells.Genetically engineered mouse models of pituitary tumorsAn astroglia-linked dopamine D2-receptor action in prefrontal cortex.Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effectsPrecision in mouse behavior genetics.Cellular and molecular specificity of pituitary gland physiology.Genomic characterization of human and rat prolactinomas.Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs.
P2860
Q24598902-5910D88F-0A89-469B-BA15-6006332F14C6Q24627768-CC4B9BA3-E864-4B86-8369-511EBC8A95A3Q24795300-5BE88B6F-BFEF-4970-9AFD-4853094B69AEQ26772167-A06529F3-70CD-45B7-BDB9-E8BFE9A941C3Q28073389-DDBB1B03-F6A3-4519-9360-FA09A9A9AF77Q28087609-29A5631B-EC7D-44EF-B471-526FFB982FBFQ28344662-0E2159D1-B081-435F-9873-B61F07378FA9Q28348761-17475046-A336-45AF-AF3C-DA04E504439DQ28510018-B77FBF83-E596-46E1-BD93-1D1D286BCF04Q28513814-2BBC9181-1D24-496E-A017-818F65730786Q28543723-DC0EC115-59A2-45EB-AB5C-EA6FDE914583Q28571661-2C6AAF96-43F3-4C30-8C49-2158EF551C32Q28580699-A6F874D9-FE72-4511-BE1D-E04E4C66ED90Q28581786-59EE0C54-5DD3-4B1E-AFC8-C87AF8CDD9FDQ28585149-AEECB2C8-BA68-4D28-90E2-9A37DC525CB7Q28590689-DBFB931C-CE79-4889-9429-A0A24A31C2CEQ28595051-CA8DCE97-E5F1-47BE-8BB4-6506BD53D20EQ30453020-1D6CC52B-17D5-4BFA-B1AC-F52D8CAEB02EQ30465985-D1051B8A-FC5F-458A-89CB-C97FFA89BA5BQ30482742-8D917147-79C6-4230-BFE1-A5DA8096D997Q30496544-6DE8F161-77EC-46C2-8833-02471D17F0EBQ30583673-8478B537-D964-4F13-853C-9DB87EA6BFABQ33379513-41BFFFAC-46A3-4F28-98CB-A4D913F86141Q33642161-9F6B90B4-B118-4E1B-A8FD-131F0F536F4EQ33654808-A4892EA7-40EC-47B6-AE73-ABD023FF56F7Q33678305-4D866B08-A3CF-48A6-B6DB-849F041B035FQ33726520-BCECB9A5-1F37-4608-AE44-0057B8EA11FCQ33849218-A514E953-F39C-4770-8B9A-C35BFCD816C3Q33862807-602B5CE7-CCDC-45A4-AACA-EFDAF1621DB8Q33895995-05B1897E-7E3D-4C90-AE81-0DE475862194Q33899741-C7CADC2F-485A-4C0E-BE5B-7A2B55CEB888Q33954415-A0B7BBB3-DC65-4452-A090-DCB3BA6D7F6FQ33962164-B165D084-A192-4B3C-ADBD-EAD664C70A50Q33984418-EE60D1B8-27A3-4546-BC89-BB16BF014DDCQ34115031-51D41EDC-961D-4B7B-98C0-AAF0D2AB46CEQ34122531-662EA2F4-DE6A-4406-8A91-D44771BD3201Q34245721-085AD05D-0ACE-42F9-96F3-E22FDCD2307CQ34251305-D3903CDD-9F8B-4EC0-AE73-852E20E0597FQ34277575-CC3ABBDB-5A58-48B7-A584-49DBC761C420Q34394799-4FA54052-F53D-4B23-89A0-E7BCF3A21AC7
P2860
Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice
description
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1997
@ast
im Juli 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/07/01)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/07/01)
@nl
наукова стаття, опублікована в липні 1997
@uk
مقالة علمية (نشرت في يوليو 1997)
@ar
name
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@ast
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@en
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@nl
type
label
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@ast
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@en
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@nl
prefLabel
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@ast
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@en
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@nl
P2093
P921
P3181
P1433
P1476
Pituitary lactotroph hyperplas ...... ine D2 receptor-deficient mice
@en
P2093
D. K. Grandy
J. R. Bunzow
M. A. Kelly
M. Rubinstein
N. Ben-Jonathan
R. G. Allen
P304
P3181
P356
10.1016/S0896-6273(00)80351-7
P407
P577
1997-07-01T00:00:00Z